Your support will fund translational studies for the development of novel drugs for the treatment of Alzheimer’s disease, Parkinson’s diseases, and dementia.
To Make Tomorrow Happen is Within Your Power
Neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, dementia, etc., are incurable, terminal illnesses characterized by progressive neurodegeneration and cognitive decline. Greater than 30 million people currently suffer from Alzheimer’s disease, and the number of Alzheimer patients is predicted to double every 20 years unless preventive measures are developed. Meanwhile, Parkinson’s disease comprises the second most common neurodegenerative disorder, with approximately 60,000 new cases being diagnosed annually in the United States alone. Indeed, Parkinson’s disease is expected to afflict greater than 10 million American citizens within the next 15 years.
At the Human Microbiology Institute, we aim to investigate the role of the human microbiota in these age-related cognitive diseases and utilize this information in translational research to develop novel therapeutic approaches. As such, your gift will accelerate the development of novel drugs for the prevention and treatment of Alzheimer’s disease, Parkinson’s diseases, and dementia.